# QIAGEN

Molecular diagnostics leader — QIAstat-Dx, QIAamp extraction kits, and QIAsymphony automation; nucleic acid extraction reagents used in 90% of global CRISPR diagnostics workflows.

Source: https://en.bioecon.ru/companies/qiagen/
Updated: 2026-06-19

- Country: Netherlands
- Revenue: $2.0B
- Employees: ~6,100 emp

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Headcount | approximately 5,700 people (2025-12-31) | https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Exceeds-Q4-2025-Outlook-Driven-by-Growth-Pillars/default.aspx, https://www.marketscreener.com/news/qiagen-n-2025-annual-report-2025-ifrs-annual-report-ce7f58d8da8df42d, https://www.sec.gov/Archives/edgar/data/1015820/000101582026000018/qgen-20251231.htm, https://www.sec.gov/Archives/edgar/data/1015820/000101582026000047/a2025ifrsannualreport36.htm, https://www.stocktitan.net/sec-filings/QGEN/20-f-qiagen-n-v-files-annual-report-foreign-issuer-abe7e9c1d1d1.html |
| Revenue | $2.09 billion (2025-12-31) | https://corporate.qiagen.com/English/newsroom/press-releases/press-release-details/2026/QIAGEN-Exceeds-Q4-2025-Outlook-Driven-by-Growth-Pillars/default.aspx, https://www.sec.gov/Archives/edgar/data/1015820/000101582026000018/R31.htm, https://www.stocktitan.net/sec-filings/QGEN/20-f-qiagen-n-v-files-annual-report-foreign-issuer-abe7e9c1d1d1.html |
| Production site | United States, Germany, Spain, and China | https://s28.q4cdn.com/125951340/files/doc_financials/2024/ar/2024-QIAGEN-Annual-Report-Glossy-Final.pdf, https://www.marketscreener.com/news/qiagen-n-2025-annual-report-2025-ifrs-annual-report-ce7f58d8da8df42d |
| Certification | ISO 9001:2015, ISO 13485:2016, and MDSAP | https://s28.q4cdn.com/125951340/files/doc_financials/2024/ar/2024-QIAGEN-Annual-Report-Glossy-Final.pdf, https://www.marketscreener.com/news/qiagen-n-2025-annual-report-2025-ifrs-annual-report-ce7f58d8da8df42d |
| Regulatory approval | FDA Quality System Regulations (cGMP) compliant | https://s28.q4cdn.com/125951340/files/doc_financials/2024/ar/2024-QIAGEN-Annual-Report-Glossy-Final.pdf, https://www.marketscreener.com/news/qiagen-n-2025-annual-report-2025-ifrs-annual-report-ce7f58d8da8df42d |
| Funding | Internally generated funds and debt offerings | https://s28.q4cdn.com/125951340/files/doc_financials/2024/ar/2024-QIAGEN-Annual-Report-Glossy-Final.pdf, https://www.marketscreener.com/news/qiagen-n-2025-annual-report-2025-ifrs-annual-report-ce7f58d8da8df42d, https://www.sec.gov/Archives/edgar/data/1015820/000101582026000047/a2025ifrsannualreport36.htm |
| Capacity | Capacity reached over 20 million patient tests per month by end of 2020 for RNA extraction kits [medium confidence] | https://www.dutchnews.nl/businesswire/qiagen-dramatically-ramping-up-global-production-capacity-for-rna-extraction-kits-for-use-in-detection-of-sars-cov-2-coronavirus/ |

Independent sources: dutchnews.nl, marketscreener.com, s28.q4cdn.com, sec.gov, stocktitan.net

## Technologies

- [Automated nucleic acid extraction](https://en.bioecon.ru/technology/automated-nucleic-acid-extraction/)
- [Biological AI & bioinformation services](https://en.bioecon.ru/technology/biological-ai-bioinformation-services/)
- [Capillary electrophoresis for biopharma](https://en.bioecon.ru/technology/capillary-electrophoresis-biopharma/)
- [CRISPR diagnostics](https://en.bioecon.ru/technology/crispr-diagnostics/)
- [Personalized diagnostics](https://en.bioecon.ru/technology/personalized-diagnostics/)
- [Sovereign genome databases (plants, animals, microbes)](https://en.bioecon.ru/technology/sovereign-genome-databases/)